Subscribe to the BioNews newsletter for free

Advanced Search

Search for
The Progress Educational Trust (PET), informing debate on assisted conception and genetics

Like the Progress Educational Trust on Facebook




EVENTS

What Next for Genomics? Providing Answers, Changing Lives, Transforming the NHS

Progress Educational Trust
Wellcome Collection, 183 Euston Road, London NW1 2BE
04 July 2017
This public event was organised by the Progress Educational Trust (PET) in partnership with Genomics England, the organisation established by the UK Government to deliver the 100,000 Genomes Project.
The event launched Generation Genome, the Annual Report of the UK's Chief Medical Officer, who was a keynote speaker. The event also launched a new phase of the Genomics Conversation, a programme of activities led by Genomics England which involves the public and stakeholders in discussions about key issues in genomic medicine.
The UK is a leader in genomic medicine, an approach to medicine in which our genomic information plays a central role in understanding, preventing, diagnosing and treating disease. The NHS is the first healthcare system in the world seeking to commission routine whole genome testing for rare diseases and cancer, work which is currently being pioneered by the 100,000 Genomes Project and by NHS England's 13 Genomic Medicine Centres.
Genomic medicine also stands to have a transformative effect on healthcare and the NHS more widely, and some benefits are already being seen. This public event saw a panel of experts - including the UK's Chief Medical Officer, Professor Dame Sally Davies - discuss what has been learned to date in genomic medicine and research, the challenges that still need to be overcome, and the benefits we stand to gain if genomics is successfully embedded into mainstream healthcare.
Questions explored included:
What progress has been made with genomics in relation to rare diseases, cancers and infectious diseases? What other conditions could benefit from genomic medicine?
How solid are the foundations for a mainstream genomic medicine service in today's NHS? What groundwork remains to be done?
When is it appropriate and useful to combine clinical services with research projects, for example the 100,000 Genomes Project? When should these things be kept distinct?
What do patients think about their genomic data being shared with researchers in the public and private sectors? What sort of consent are they required to give? What are their hopes and fears, and how can these be addressed?
How can we best support clinicians in different disciplines in making use of genomics? And how can we involve other healthcare workers, such as nurses?

Speakers:
Professor Dame Sally Davies
Chief Medical Officer at the UK Government
Professor Sue Hill
Chief Scientific Officer at NHS England, and Senior Responsible Officer for the NHS Genomics Programme
Sir Stephen O'Rahilly
Professor of Clinical Biochemistry and Medicine, Head of Clinical Biochemistry and Director of Metabolic Research Laboratories at the University of Cambridge
Michael Parker
Professor of Bioethics, and Director of the Ethox Centre and the Centre for Ethics, Innovation, Globalisation and Medicine, at the University of Oxford

Chair:
Mark Henderson
Director of Communications at the Wellcome Trust

Partners and supporters:

Datalabel The UK's Leading Supplier Of Medical Labels & Asset Labels

 
Subscribe to BioNews for FREE HERE
 
Good Fundraising Code
 
Find out more about the Progress Educational Trust by downloading our brochure HERE

Advertising & sponsorship
Terms & conditions
Sitemap

Progress Educational Trust, 140 Grays Inn Road, London WC1X 8AX, UK
Tel: +44 (0)20 7278 7870 Email:
Limited company registered in England and Wales no 7405980
Registered charity no 1139856

Website developed and built by Face to Face
Website designed by Thunder
Website administration

© 1992, 2017
Progress Educational Trust